Citation only
via Europe PMC
ECM-Targeted and cell-based therapies in musculoskeletal and aging-related disorders: A review.
Technology and health care : official journal of the European Society for Engineering and Medicine · 2026
Abstract
BackgroundExtracellular matrix (ECM) stiffness is increasingly recognized as a key pathological factor in musculoskeletal and aging-related disorders. Although cell-based therapies-particularly mesenchymal stem cells (MSCs)-hold regenerative potential, their effectiveness is significantly reduced in fibrotic and mechanically rigid environments.ObjectiveThis review compares ECM-targeted and cell-based therapies, with a focus on their mechanistic basis, limitations, and potential for integration in regenerative strategies.SummaryPathological ECM stiffening, driven by lysyl oxidase (LOX)-mediated collagen crosslinking, chronic inflammation, and Piezo channel activation, alters cell-matrix interactions and promotes tissue degeneration. Therapeutic interventions such as LOX inhibitors, low-intensity pulsed ultrasound (LIPUS), and antifibrotic agents show promise in reversing matrix rigidity and restoring tissue biomechanics. In contrast, the success of MSC therapies is often hindered by impaired viability, reduced paracrine activity, and disrupted immunomodulation in stiffened ECM. Mechanosensitive pathways-including YAP/TAZ, integrins, and Piezo1/2-play critical roles in mediating this dysfunction.ConclusionEffective tissue regeneration requires a permissive mechanical and biochemical microenvironment. Rather than treating ECM remodeling as ancillary, it should be prioritized as a foundational therapeutic target. Preconditioning the ECM enhances the efficacy of cell-based therapies, suggesting that matrix normalization is essential for long-term regenerative success. Targeting ECM stiffness may therefore represent the most decisive step in overcoming barriers to musculoskeletal and aging-related tissue repair.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.1177/09287329251414507
- Canonical
- link ↗
- Fetched
- 2026-07-01 MST
Cite this
APA
K, A., & H., P. (2026). ECM-Targeted and cell-based therapies in musculoskeletal and aging-related disorders: A review. <em>Technology and health care : official journal of the European Society for Engineering and Medicine</em>. https://doi.org/10.1177/09287329251414507
Vancouver
K A, H. P. ECM-Targeted and cell-based therapies in musculoskeletal and aging-related disorders: A review. Technology and health care : official journal of the European Society for Engineering and Medicine. 2026. doi:10.1177/09287329251414507.
BibTeX
@article{ahn2026ECMTar,
title = {ECM-Targeted and cell-based therapies in musculoskeletal and aging-related disorders: A review.},
author = {Ahn K and Park H.},
journal = {Technology and health care : official journal of the European Society for Engineering and Medicine},
year = {2026},
doi = {10.1177/09287329251414507},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Frontiers in Pharmacology 2020
Open access · CC-BY
The Bone Extracellular Matrix in Bone Formation and Regeneration
Molecular biology reports 2026
Citation only
Musculoskeletal degeneration and cardiovascular aging: a narrative review of shared mechanobiological pathways.
The Journal of Pathology 2012
Open access · OA
The myofibroblast matrix: implications for tissue repair and fibrosis
Clinical Science 2021
Preprint · CC-BY
Interplay between extracellular matrix components and cellular and molecular mechanisms in kidney fibrosis
Science Translational Medicine 2018
Citation only
Targeting extracellular matrix stiffness to attenuate disease: From molecular mechanisms to clinical trials
Signal Transduction and Targeted Therapy 2022
Open access · CC-BY